Prosecution Insights
Last updated: May 29, 2026

Examiner: COHEN, MICHAEL P

Tech Center 1600 • Art Units: 1600 1612 1628

This examiner grants 58% of resolved cases

Performance Statistics

58.5%
Allow Rate
-1.5% vs TC avg
886
Total Applications
+27.6%
Interview Lift
1057
Avg Prosecution Days
Based on 837 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
3.1%
§102 Novelty
73.7%
§103 Obviousness
2.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18699416 OCULAR DRUG DELIVERY DEVICE AND RELATED METHODS Non-Final OA Purdue Research Foundation
18647746 INJECTABLE SHEAR-THINNING COMPOSITIONS AND USES THEREOF Non-Final OA Boston Scientific Scimed, Inc.
17622587 ROSEBUSH EXTRACT Non-Final OA L'OREAL
17633889 LIQUID DRESSING COMPOSITIONS AND THEIR USES Non-Final OA Cambridge Enterprise Limited
18700293 DIHYDROCHALCONE DERIVATIVES Non-Final OA SYMRISE AG
18253073 METHODS OF INCREASING HEIGHT AND PROMOTING LINEAR BONE GROWTH Non-Final OA ABBOTT LABORATORIES
18342056 NOVEL ANTICARIES MATERIAL FOR DENTAL USE Final Rejection The University of Hong Kong
18716833 HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION Non-Final OA Conopco, Inc., d/b/a UNILEVER
18674209 POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF Non-Final OA Yale University
18711430 ULTRA LONG ACTING PHARMACEUTICAL COMPOSITION COMPRISING INSULIN Non-Final OA Yong Soo JUN
18667477 Method for Preparing an Intramammary Teat Sealing Composition and Sealing Composition Obtained By Such Process Non-Final OA Filid Tecnologia Farmacêutica Ltda (ME)
18647613 Tinted Deodorant Composition Non-Final OA C'EST TOUT STUDIO
18698471 CHITOSAN-BASED SWELLING GEL Non-Final OA UNIVERSITE JEAN MONNET SAINT ETIENNE
18607819 COATING FOR A BIORESORBABLE SCAFFOLD Non-Final OA Shanghai Bioresorbable Scaffold Technology Co. Ltd.
17753829 AGRICULTURAL INERT PACKAGE FORMULATION CONTAINING A SULFOPOLYMER Final Rejection Eastman Chemical Company
18438087 USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION Non-Final OA Invion, Inc.
17776561 PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER Final Rejection CELGENE CORPORATION
18406327 ANTIVIRAL COMPOSITIONS AND METHODS Final Rejection RALCO NUTRITION, INC.
18571559 HAIR GROWTH AGENT Non-Final OA ADJUVANT HOLDINGS CO., LTD.
18538605 FORMULATIONS FOR TREATING ACID REFLUX COMPRISING SODIUM ALGINATE Non-Final OA PHARAGEN LLC
18533368 COMPOSITIONS OF TAURINE AND MALIC ACID AND METHODS OF MAKING THE COMPOSITIONS Non-Final OA NutriScience Innovations LLC
18375604 REVERSIBLY PROTECTED COLORANTS AND METHODS OF USE Non-Final OA Kinnos Inc.
18368780 PRESERVATIVE COMPOSITIONS Final Rejection Dermegen Inc.
18458487 HIGH TRANSPARENCY AND LONG-RELEASE DENTAL RESIN COMPOSITION CONTAINING CORE-SHELL POROUS STRUCTURED NANOPARTICLES AND METHOD FOR PREPARING THE SAME Non-Final OA MIMETICS.Co., Ltd.
18246494 DENTAL COMPOSITION Final Rejection TERAUCHI ENDO institute
17327922 BAKUCHIOL COMPOSITIONS FOR TREATMENT OF POST INFLAMMATORY HYPERPIGMENTATION Final Rejection Unigen, Inc.
18147643 METHOD OF TREATING SURFACES Final Rejection SANIPUR S.P.A.
17952108 LINKERS FOR IMPROVING THE STABILITY OF BIOCONJUGATES AND THE SELECTIVITY OF PAYLOAD RELEASE Non-Final OA EQIP, LLC
16943851 GASTRORETENTIVE FORMULATIONS Non-Final OA Rubicon Research Private Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month